- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Parexel
Total 511 results
-
AstraZenecaParexelNot yet recruiting
-
AstraZenecaParexelRecruitingDilated CardiomyopathyUnited States
-
AstraZenecaParexelRecruiting
-
AstraZenecaParexelRecruitingMajor BleedingUnited States, Japan, Germany
-
AstraZenecaParexelRecruitingHealthy VolunteersUnited States, Germany
-
AstraZenecaParexelNot yet recruitingCutaneous Lupus ErythematosusUnited States, Italy, France, Germany, China, Spain, Australia, Austria, Netherlands, Bulgaria, Philippines, Taiwan, Poland, Argentina, Chile, Brazil, Greece, Colombia
-
AstraZenecaParexelRecruitingAdvanced or Metastatic Non-Small Cell Lung CancerChina, Netherlands, Korea, Republic of, Italy, Spain, Canada, Hungary, Japan, Argentina, France, United States, Taiwan, Poland, Serbia, United Kingdom, Hong Kong, Brazil, Germany, Belgium, Romania, India, Ireland, Australia
-
AstraZenecaParexelRecruitingRelapsed or Refractory Classical Hodgkin LymphomaItaly, United States, Spain, United Kingdom, Canada, Denmark, France, China, Germany
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
AstraZenecaParexelTerminatedType 2 DiabetesUnited States
-
AstraZenecaParexelCompletedHealthy Male SubjectsUnited States
-
AstraZenecaParexelCompletedHealthy VolunteersUnited States
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease | Asthma | COPDUnited States, Canada, Germany, Italy, Spain, United Kingdom, Mexico, Australia, Argentina, France, China, Japan, Brazil, Korea, Republic of, Colombia, Denmark, Netherlands, Norway, Sweden
-
AstraZenecaParexelCompletedChronic Kidney DiseaseGermany
-
AstraZenecaParexelTerminated
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited States, Spain
-
AstraZenecaParexelCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaParexelCompletedCOPDPhilippines, Vietnam, China, Taiwan, India
-
AstraZenecaParexelCompletedChronic Kidney DiseaseUnited Kingdom
-
AstraZenecaParexelCompletedCOVID-19United Kingdom
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
ItalfarmacoParexelTerminatedJuvenile Idiopathic ArthritisCzechia
-
GlaxoSmithKlineParexelCompleted
-
AstraZenecaParexelCompletedCOVID-19 | Mantle Cell LymphomaGermany
-
AstraZenecaParexelCompletedAsthmaUnited States, Germany, South Africa, Ukraine, Japan, Hungary, Poland, Bulgaria
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited Kingdom
-
GlaxoSmithKlineParexelTerminatedNeoplasms, PancreaticUnited States
-
AffibodyParexelTerminatedHealthy VolunteersUnited Kingdom
-
AstraZenecaParexelTerminatedChronic Obstructive Pulmonary DiseaseGermany
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompletedCoronary Artery DiseaseUnited Kingdom
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease | AsthmaGermany
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
GlaxoSmithKlineParexelCompletedAsthmaUnited States, Australia, Spain, Taiwan, Bulgaria, Russian Federation, Ukraine, Argentina, Germany, Peru, Poland, South Africa, Thailand, Korea, Republic of, Austria, Belgium, Hungary, Italy, Slovakia, Malaysia, Czechia, Mexico, United... and more
-
AstraZenecaParexelCompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)Germany
-
AstraZenecaParexelTerminated
-
GlaxoSmithKlineParexelCompleted
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
BayerParexelCompleted
-
AstraZenecaParexelRecruitingAsthmaKorea, Republic of, Spain, United States, Argentina, France, Italy, Taiwan, Germany, United Kingdom, Poland, Canada
-
AstraZenecaParexelRecruitingSystemic Lupus ErythematosusItaly, Belgium, Germany, France, Canada, Austria, Sweden, Denmark, Israel, United Arab Emirates